Latest filing published 15 May 2018 for Anaptysbio, INC. Read the official filing
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Frazier Healthcare V, LP across 2 companies, led by Anaptysbio, Inc and Tobira Therapeutics, Inc. The record holds 10 filings, for trades running from 1 November 2016 to 11 May 2018.
On the market, this insider has only ever bought: 2 purchases, €5.6M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant.
On 15 May 2018 came the latest disclosure, a transaction in Anaptysbio, Inc. The last insider purchase was made public on 31 January 2017, 3,550 days ago. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations